At-Home sample test could spot uterine cancer early

NCT ID NCT06846775

Recruiting now Diagnosis Sponsor: University of Aarhus Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a new, non-invasive way to detect endometrial cancer using DNA methylation testing on urine and vaginal samples collected by patients themselves. Researchers will compare samples from 120 women—half with endometrial cancer and half healthy—to see if the test can accurately tell the two groups apart. If successful, this could lead to a simple, patient-friendly screening tool that avoids uncomfortable procedures.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

endometrial cancer endometrium neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ENDOMETRIAL CANCER

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Department of Obstetrics and Gynaecology, Aarhus University Hospital
RECRUITING

Aarhus N, 8200, Denmark

Contact Phone: •••-•••-•••• Email: •••••@•••••
Department of Obstetrics and Gynaecology, Odense University Hospital
RECRUITING

Odense, 5000, Denmark

Contact Phone: •••-•••-•••• Email: •••••@•••••
Department of Orthopaedics, Randers Regional Hospital
RECRUITING

Randers, 8930, Denmark

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.